Request Trial
canada-istock-471706898-mironovak--2
mironovak / iStockphoto.com
2 October 2017Ron Dimock, Sangeetha Punniyamoorthy and Nikolas Purcell

Why you shouldn’t overlook Canadian IP litigation

While Canada is known for its natural resources and universal healthcare, it is often overlooked as a jurisdiction to litigate IP disputes.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Careers
Moderna VP and regulatory expert moves to private practice
2 February 2026   The third European life sciences hire in recent months brings in-house regulatory expertise from Moderna in Munich.
Careers
Winston & Strawn and Taylor Wessing UK seal ‘powerhouse’ merger
30 January 2026   Transatlantic ‘powerhouse’ Winston Taylor is set to launch in May 2026, with a particular focus on technology, life sciences and transatlantic services.
Careers
Pearce IP grows practice with senior patent hire
29 January 2026   Melbourne-based firm adds senior attorney with over 25 years of experience in therapeutics, diagnostics and biologics as demand for specialist patent services rises.


Editor's picks

The quantum advantage: IP considerations for the next generation of life sciences innovation
Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026

Editor's picks

Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026
Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025
Americas
US govt backs Hikma over ‘skinny label’ rules
9 December 2025

More features

Rooted in rights: Lessons from plant patent infringement and invalidity cases
How AI will be shaped by legal and regulatory developments in 2026
Key EU and UK regulatory changes to watch for in 2026
Regeneron v Alvotech: The big impact
Beyond traditional IP: A comprehensive AI strategy for life sciences
Prosecuting bispecific antibody patents: A cookbook for patent chefs
EU Pharma Package hits the final stretch—but can negotiators agree?
The clinical trial dilemma: Navigating European practice